SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
28
12
2020
accepted:
26
08
2022
pubmed:
6
10
2022
medline:
15
10
2022
entrez:
5
10
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and caused the devastating global pandemic of coronavirus disease 2019 (COVID-19), in part because of its ability to effectively suppress host cell responses
Identifiants
pubmed: 36198800
doi: 10.1038/s41586-022-05282-z
pii: 10.1038/s41586-022-05282-z
pmc: PMC9533993
doi:
Substances chimiques
Chromatin
0
Histones
0
ORF8 protein, SARS-CoV-2
0
Viral Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-388Subventions
Organisme : NCI NIH HHS
ID : P01 CA196539
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118891
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD106051
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL140018
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Type : ErratumIn
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
doi: 10.1126/science.abc6027
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045 (2020).
doi: 10.1016/j.cell.2020.04.026
Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl Acad. Sci. USA 118, e2022643118 (2021).
doi: 10.1073/pnas.2022643118
Marazzi, I. et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483, 428–433 (2012).
doi: 10.1038/nature10892
Schaefer, U., Ho, J. S. Y., Prinjha, R. K. & Tarakhovsky, A. The ‘histone mimicry’ by pathogens. Cold Spring Harb. Symp. Quant. Biol. 78, 81–90 (2013).
doi: 10.1101/sqb.2013.78.020339
Avgousti, D. C. et al. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature 535, 173–177 (2016).
doi: 10.1038/nature18317
Avgousti, D. C. et al. Adenovirus core protein VII downregulates the DNA damage response on the host genome. J. Virol. 91, e01089-17 (2017).
doi: 10.1128/JVI.01089-17
Tarakhovsky, A. & Prinjha, R. K. Drawing on disorder: how viruses use histone mimicry to their advantage. J. Exp. Med. 215, 1777–1787 (2018).
doi: 10.1084/jem.20180099
Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).
doi: 10.1038/47412
Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074–1080 (2001).
doi: 10.1126/science.1063127
Berger, S. L. The complex language of chromatin regulation during transcription. Nature 447, 407–412 (2007).
doi: 10.1038/nature05915
Ho, J. S. Y. et al. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell 184, 2618–2632 (2021).
doi: 10.1016/j.cell.2021.03.051
Lee, S. et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 599, 283–289 (2021).
doi: 10.1038/s41586-021-03995-1
Zazhytska, M. et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 185, 1052–1064 (2022).
doi: 10.1016/j.cell.2022.01.024
Elde, N. C. & Malik, H. S. The evolutionary conundrum of pathogen mimicry. Nat. Rev. Microbiol. 7, 787–797 (2009).
doi: 10.1038/nrmicro2222
Davey, N. E., Travé, G. & Gibson, T. J. How viruses hijack cell regulation. Trends Biochem. Sci. 36, 159–169 (2011).
doi: 10.1016/j.tibs.2010.10.002
Chaurushiya, M. S. et al. Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain. Mol. Cell 46, 79–90 (2012).
doi: 10.1016/j.molcel.2012.02.004
Chan, J. F.-W. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221–236 (2020).
doi: 10.1080/22221751.2020.1719902
Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020).
doi: 10.1016/S0140-6736(20)30251-8
Yuen, K.-S., Ye, Z.-W., Fung, S.-Y., Chan, C.-P. & Jin, D.-Y. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 10, 40 (2020).
doi: 10.1186/s13578-020-00404-4
Sampath, S. C. et al. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol. Cell 27, 596–608 (2007).
doi: 10.1016/j.molcel.2007.06.026
Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459–468 (2020).
doi: 10.1038/s41586-020-2286-9
Vann, K. R. et al. Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection. Structure 30, 1224–1232 (2022).
doi: 10.1016/j.str.2022.05.020
Flower, T. G. et al. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl Acad. Sci. USA 118, e2021785118 (2021).
Muth, D. et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci. Rep. 8, 15177 (2018).
doi: 10.1038/s41598-018-33487-8
Hachim, A. et al. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat. Immunol. 21, 1293–1301 (2020).
doi: 10.1038/s41590-020-0773-7
Wang, X. et al. Accurate diagnosis of COVID-19 by a novel immunogenic secreted SARS-CoV-2 orf8 protein. mBio 11, e02431-20 (2020).
doi: 10.1128/mBio.02431-20
Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469–472 (2020).
doi: 10.1038/s41586-020-2332-7
Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685–712 (2020).
doi: 10.1016/j.cell.2020.06.034
Zhang, Y. et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι. Proc. Natl Acad. Sci. USA 118, e2024202118 (2021).
Rashid, F. et al. Mutations in SARS-CoV-2 ORF8 altered the bonding network with interferon regulatory factor 3 to evade host immune system. Front. Microbiol. 12, 703145 (2021).
doi: 10.3389/fmicb.2021.703145
Rashid, F., Dzakah, E. E., Wang, H. & Tang, S. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon β. Virus Res. 296, 198350 (2021).
doi: 10.1016/j.virusres.2021.198350
Geng, H. et al. SARS-CoV-2 ORF8 forms intracellular aggregates and inhibits IFNγ-induced antiviral gene expression in human lung epithelial cells. Front. Immunol. 12, 679482 (2021).
doi: 10.3389/fimmu.2021.679482
Lin, X. et al. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience 24, 102293 (2021).
doi: 10.1016/j.isci.2021.102293
Wu, X. et al. Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8. mBio 13, e0040222 (2022).
doi: 10.1128/mbio.00402-22
Chen, J. et al. Severe acute respiratory syndrome coronavirus 2 ORF8 protein inhibits type I interferon production by targeting HSP90B1 signaling. Front. Cell. Infect. Microbiol. 12, 899546 (2022).
doi: 10.3389/fcimb.2022.899546
Li, J.-Y. et al. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. 286, 198074 (2020).
doi: 10.1016/j.virusres.2020.198074
Matsuoka, K. et al. SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer. J. Biol. Chem. 298, 101724 (2022).
doi: 10.1016/j.jbc.2022.101724
Ohki, S., Imamura, T., Higashimura, Y., Matsumoto, K. & Mori, M. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant. Biochem. Biophys. Res. Commun. 563, 92–97 (2021).
doi: 10.1016/j.bbrc.2021.05.074
Zinzula, L. Lost in deletion: the enigmatic ORF8 protein of SARS-CoV-2. Biochem. Biophys. Res. Commun. https://doi.org/10.1016/j.bbrc.2020.10.045 (2020).
Xie, X. et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27, 841–848 (2020).
doi: 10.1016/j.chom.2020.04.004
Xie, X. et al. Engineering SARS-CoV-2 using a reverse genetic system. Nat. Protoc. 16, 1761–1784 (2021).
doi: 10.1038/s41596-021-00491-8
Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl Acad. Sci. USA 118, e2022643118 (2021).
Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303–3332 (2019).
doi: 10.1038/s41596-019-0220-0
Wang, R. et al. SARS-CoV-2 restructures the host chromatin architecture. Preprint at bioRxiv https://doi.org/10.1101/2021.07.20.453146 (2021).
Valcarcel, A., Bensussen, A., Álvarez-Buylla, E. R. & Díaz, J. Structural analysis of SARS-CoV-2 ORF8 protein: pathogenic and therapeutic implications. Front. Genet. 12, 693227 (2021).
doi: 10.3389/fgene.2021.693227
Silvas, J. A. et al. Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice. J. Virol. 95, e0040221 (2021).
doi: 10.1128/JVI.00402-21
Young, B. E. et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 396, 603–611 (2020).
doi: 10.1016/S0140-6736(20)31757-8
Fong, S.-W. et al. Robust virus-specific adaptive immunity in COVID-19 patients with SARS-CoV-2 Δ382 variant infection. J. Clin. Immunol. https://doi.org/10.1007/s10875-021-01142-z (2021).
DeRonde, S., Deuling, H., Parker, J. & Chen, J. Identification of a novel SARS-CoV-2 variant with a truncated protein in ORF8 gene by next generation sequencing. Sci. Rep. 12, 4631 (2022).
doi: 10.1038/s41598-022-08780-2
Porter, E. G., Connelly, K. E. & Dykhuizen, E. C. Sequential salt extractions for the analysis of bulk chromatin binding properties of chromatin modifying complexes. J. Vis. Exp. https://doi.org/10.3791/55369 (2017).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
doi: 10.1093/bioinformatics/btu170
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
doi: 10.1186/gb-2008-9-9-r137
Stark, R. & Brown, G. DiffBind https://doi.org/10.18129/B9.BIOC.DIFFBIND (2017).
Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).
doi: 10.1038/s41586-020-2008-3
Sidoli, S., Bhanu, N. V., Karch, K. R., Wang, X. & Garcia, B. A. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. J. Vis. Exp. https://doi.org/10.3791/54112 (2016).
Lin, S. et al. Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry. Mol. Cell. Proteomics 13, 2450–2466 (2014).
doi: 10.1074/mcp.O113.036459
Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S. & Coon, J. J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11, 1475–1488 (2012).
doi: 10.1074/mcp.O112.020131
MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966–968 (2010).
doi: 10.1093/bioinformatics/btq054
Brademan, D. R., Riley, N. M., Kwiecien, N. W. & Coon, J. J. Interactive Peptide Spectral Annotator: a versatile web-based tool for proteomic applications. Mol. Cell. Proteomics 18, S193–S201 (2019).
doi: 10.1074/mcp.TIR118.001209
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2022).
doi: 10.1093/nar/gkab1038